Nextage Therapeutics Ltd (TLV:NXTG)
38.10
+3.00 (8.55%)
Nov 20, 2026, 1:44 PM IST
Nextage Therapeutics Market Cap
Nextage Therapeutics has a market cap or net worth of 30.89 million as of November 20, 2026. It is the 41,528th most valuable company in the world and the 432nd biggest in Israel. Its market cap has increased by 17.66% in one year.
Market Cap
30.89M
Enterprise Value
38.01M
Revenue
2.51M
Global Rank
Country Rank
#432 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since February 29, 2024, Nextage Therapeutics's market cap has increased from 12.50M to 30.89M, an increase of 147.06%. That is a compound annual growth rate of 39.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 30.89M | 29.98% |
| Dec 31, 2024 | 23.76M | 90.07% |
| Feb 29, 2024 | 12.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.50B |
| Amal Holdings A.D. | 2.12B |
| Rafa Laboratories | 1.61B |
| Kamada | 1.51B |
| Purple Biotech | 32.42M |
| Together Pharma | 31.36M |
| Clal Biotechnology Industries | 30.11M |
| BioLineRx | 29.87M |